小儿肝脏肿瘤的影像学表现：COG 诊断成像委员会/SPR 肿瘤学委员会白皮书。
Imaging of pediatric liver tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
机构信息
Department of Radiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
Department of Radiology, Nemours Children's Health, Orlando, Florida, USA.
出版信息
Pediatr Blood Cancer. 2023 Jun;70 Suppl 4(Suppl 4):e29965. doi: 10.1002/pbc.29965. Epub 2022 Sep 14.
Abstract
Primary hepatic malignancies are relatively rare in the pediatric population, accounting for approximately 1%-2% of all pediatric tumors. Hepatoblastoma and hepatocellular carcinoma are the most common primary liver malignancies in children under the age of 5 years and over the age of 10 years, respectively. This paper provides consensus-based imaging recommendations for evaluation of patients with primary hepatic malignancies at diagnosis and follow-up during and after therapy.
摘要
原发性肝恶性肿瘤在儿科人群中相对少见，约占所有儿科肿瘤的 1%-2%。肝母细胞瘤和肝细胞癌分别是 5 岁以下和 10 岁以上儿童中最常见的原发性肝脏恶性肿瘤。本文提供了基于共识的影像学建议，用于评估原发性肝恶性肿瘤患者的诊断、治疗期间和治疗后的随访。
相似文献
1
Imaging of pediatric liver tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Pediatr Blood Cancer. 2023 Jun;70 Suppl 4(Suppl 4):e29965. doi: 10.1002/pbc.29965. Epub 2022 Sep 14.
2
2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric Hepatic International Tumour Trial (PHITT).
Pediatr Radiol. 2018 Apr;48(4):536-554. doi: 10.1007/s00247-018-4078-z. Epub 2018 Feb 9.
3
Pediatric Hepatoblastoma, Hepatocellular Carcinoma, and Other Hepatic Neoplasms: Consensus Imaging Recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group.
Radiology. 2020 Sep;296(3):493-497. doi: 10.1148/radiol.2020200751. Epub 2020 Jun 30.
4
Imaging of pediatric bone tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Pediatr Blood Cancer. 2023 Jun;70 Suppl 4(Suppl 4):e30000. doi: 10.1002/pbc.30000. Epub 2022 Oct 17.
5
Imaging of pediatric renal tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper focused on Wilms tumor and nephrogenic rests.
Pediatr Blood Cancer. 2023 Jun;70 Suppl 4(Suppl 4):e30004. doi: 10.1002/pbc.30004. Epub 2022 Oct 29.
6
Role of interventional radiology in managing pediatric liver tumors : Part 2: percutaneous interventions.
Pediatr Radiol. 2018 Apr;48(4):565-580. doi: 10.1007/s00247-018-4072-5. Epub 2018 Feb 2.
7
Imaging of pediatric cardiac tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Pediatr Blood Cancer. 2023 Jun;70 Suppl 4(Suppl 4):e29955. doi: 10.1002/pbc.29955. Epub 2022 Sep 9.
8
Role of interventional radiology in managing pediatric liver tumors : Part 1: Endovascular interventions.
Pediatr Radiol. 2018 Apr;48(4):555-564. doi: 10.1007/s00247-018-4068-1. Epub 2018 Jan 23.
9
The comparison of grey-scale ultrasonic and clinical features of hepatoblastoma and hepatocellular carcinoma in children: a retrospective study for ten years.
BMC Gastroenterol. 2011 Jun 25;11:78. doi: 10.1186/1471-230X-11-78.
10
Imaging of pediatric pancreas tumors: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper.
Pediatr Blood Cancer. 2023 Jun;70 Suppl 4(Suppl 4):e29975. doi: 10.1002/pbc.29975. Epub 2022 Oct 10.
引用本文的文献
1
Best practices for pediatric liver MRI: guidelines from members of the Society for Pediatric Radiology Magnetic Resonance and Abdominal Imaging Committees.
Pediatr Radiol. 2025 Sep 10. doi: 10.1007/s00247-025-06383-3.
2
MRI major and ancillary features of LI-RADS for diagnosis of pediatric malignant liver tumors.
Eur Radiol. 2025 Jun 25. doi: 10.1007/s00330-025-11775-y.
3
Hepatoblastoma.
Nat Rev Dis Primers. 2025 May 22;11(1):36. doi: 10.1038/s41572-025-00620-7.
4
Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy.
Front Oncol. 2023 Oct 13;13:1276175. doi: 10.3389/fonc.2023.1276175. eCollection 2023.
5
Colorectal liver metastases patients prognostic assessment: prospects and limits of radiomics and radiogenomics.
Infect Agent Cancer. 2023 Mar 16;18(1):18. doi: 10.1186/s13027-023-00495-x.
本文引用的文献
1
Factors influencing recurrence after complete remission in children with hepatoblastoma: A 14-year retrospective study in China.
PLoS One. 2021 Nov 29;16(11):e0259503. doi: 10.1371/journal.pone.0259503. eCollection 2021.
2
Ten rules for ordering chest CTs.
Pediatr Pulmonol. 2021 Jul;56(7):1868-1871. doi: 10.1002/ppul.25399. Epub 2021 Apr 14.
3
Liver magnetic resonance imaging: how we do it.
Pediatr Radiol. 2022 Feb;52(2):167-176. doi: 10.1007/s00247-021-05053-4. Epub 2021 Apr 2.
4
Artificial intelligence in assessment of hepatocellular carcinoma treatment response.
Abdom Radiol (NY). 2021 Aug;46(8):3660-3671. doi: 10.1007/s00261-021-03056-1. Epub 2021 Mar 31.
5
Imaging and clinical features of pediatric hepatocellular carcinoma.
Pediatr Radiol. 2021 Jul;51(8):1339-1347. doi: 10.1007/s00247-021-04989-x. Epub 2021 Mar 10.
6
Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellular Carcinoma.
Radiology. 2021 Apr;299(1):190-199. doi: 10.1148/radiol.2021203559. Epub 2021 Feb 23.
7
Prognostic role of artificial intelligence among patients with hepatocellular cancer: A systematic review.
World J Gastroenterol. 2020 Nov 14;26(42):6679-6688. doi: 10.3748/wjg.v26.i42.6679.
8
Pediatric Hepatoblastoma, Hepatocellular Carcinoma, and Other Hepatic Neoplasms: Consensus Imaging Recommendations from American College of Radiology Pediatric Liver Reporting and Data System (LI-RADS) Working Group.
Radiology. 2020 Sep;296(3):493-497. doi: 10.1148/radiol.2020200751. Epub 2020 Jun 30.
9
Radiomics in liver diseases: Current progress and future opportunities.
Liver Int. 2020 Sep;40(9):2050-2063. doi: 10.1111/liv.14555. Epub 2020 Jul 2.
10
Updates on Imaging of Liver Tumors.
Curr Oncol Rep. 2020 Apr 16;22(5):46. doi: 10.1007/s11912-020-00907-w.
Zotero 插件